Advertisement

Aligos Therapeutics, Inc. ALGS

Set alert

Price alert · ALGS

All alert types
4.80 USD -0.23 -4.57%

At close · Oct 30

4.69 -0.11 -2.29%

After hours · Oct 30, 4:00 PM ET

Bid
4.76 × 2
Ask
4.98 × 2
4.75 Day range 5.05
4.08 52-week range 13.30
YTD
-48.50%
1 year
-41.46%
Open
4.92
Prev close
5.03
Mkt cap
29.97M
Vol
23.85K
Avg vol
72.68K
EPS
-7.41
P/E
0.00
Div yield
0.00%
More statistics
Low
4.75
High
5.05
Forward P/E
-3.30
Beta
2.12
Short ratio
0.50
Inst. own
48.86%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
19.24
200-d avg
16.32
1y target
103.33

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ALGS has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $3.20MExpenses → Selling, General & Admin: $5.62MExpenses → Research & Development: $24.05MExpenses → Income Tax: $2.81MGross Profit → Expenses: $27.78MRevenue → Gross Profit: $27.78MNet Loss → Expenses: $1.50MOther Income$3.20MGross Profit$27.78MNet Loss$1.50MExpenses$32.48MSelling, General & Admin$5.62MResearch & Development$24.05MIncome Tax$2.81MRevenue$27.78M

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

ALGS quarterly income statement
27.78M
27.78M
27.78M
29.67M
24.05M
5.62M
-1.89M
-221.00K
2.81M
-1.50M
-1.50M
-1.50M
-1.50M
-0.14
-0.14
-0.14
1.09M
1.09M
10.43M
10.43M

Balance sheet

ALGS quarterly balance sheet
30.42M
30.42M
27.78M
62.13M
3.44M
66.33M
3.22M
3.50M
28.34M
288.00K
34.44M
-666.75M
437.00K
31.88M
31.88M
4.20M
3.50M
6.10M
6.43M

Cash flow

ALGS quarterly cash flow
728.00K
220.00K
269.00K
-1.00K
236.00K
-16.00K
25.00M
25.00M
-24.95M
1.36M
Advertisement